Coherus Oncology, Inc. CHRS
NASDAQ · United States · Health Technology
$1.18+0.02 (+1.72%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-05 | -0.22 | -0.25 | +12.0% | $14.31M | -0.7% | -14.5%$1.48→$1.26 |
| Q1 2026 | 2026-05-11 | -0.25 | -0.26 | +3.8% | — | — | -2.3%$1.75→$1.71 |
| Q4 2025 | 2026-03-09 | -0.34 | -0.33 | -3.0% | — | — | +7.1%$1.82→$1.95 |
| Q3 2025 | 2025-11-06 | -0.33 | -0.29 | -13.8% | — | — | -14.4%$1.57→$1.34 |
| Q1 2025 | 2025-05-12 | -0.35 | -0.22 | -59.1% | — | — | — |
| Q4 2024 | 2025-03-10 | -0.28 | -0.13 | -115.4% | — | — | — |
| Q3 2024 | 2024-11-06 | -0.01 | -0.11 | +90.9% | — | — | — |
| Q2 2024 | 2024-08-08 | -0.14 | -0.26 | +46.2% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.